USPTO Patent Application for Photoprotective System
Summary
The USPTO has published a patent application (US20260083654A1) for a photoprotective system consisting of four specific sunscreens, assigned to PIERRE FABRE DERMO-COSMETIQUE. The application details a cosmetic or pharmaceutical composition with a photoprotective system representing 4% to 20% by weight.
What changed
The United States Patent and Trademark Office (USPTO) has published patent application US20260083654A1, filed on November 24, 2025, by PIERRE FABRE DERMO-COSMETIQUE. The application describes a photoprotective system comprising four specific chemical compounds: 5,6,5′,6′-tetraphenyl-3,3′-(1,4-phenylene)-bis[1,2,4]triazine, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and a solar filter from a specified group. This system is intended for use in cosmetic or pharmaceutical compositions, where it constitutes between 4% and 20% of the total weight.
This publication represents a new patent application and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future intellectual property protection for PIERRE FABRE DERMO-COSMETIQUE concerning this photoprotective system. Companies operating in the pharmaceutical and cosmetic sectors should be aware of this filing as it may impact future product development and market exclusivity in the area of sun protection formulations.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHOTOPROTECTIVE SYSTEM CONSISTING OF 4 SUNSCREENS
Application US20260083654A1 Kind: A1 Mar 26, 2026
Assignee
PIERRE FABRE DERMO-COSMETIQUE
Inventors
Roxane PROVOST, Stéphanie PAULET, Hélène DROMIGNY, Valérie PERIER
Abstract
The present invention relates to a cosmetic or pharmaceutical composition comprising at least one cosmetically or pharmaceutically acceptable excipient and a photoprotective system consisting of: (a) 5,6,5′,6′-tetraphenyl-3,3′-(1,4-phenylene)-bis[1,2,4]triazine, (b) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (c) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and (d) a solar filter selected from the group comprised of ethylhexyl triazone, diethylhexyl butamido triazone and 2-ethylhexyl salicylate, wherein the photoprotective system represents between 4% and 20% by weight of the composition relative to the total weight of the composition.
CPC Classifications
A61K 8/4966 A61K 8/06 A61K 8/37 A61K 8/411 A61Q 17/04 A61K 2800/30 A61K 2800/412 A61K 2800/5922
Filing Date
2025-11-24
Application No.
19398527
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.